MARKET

RDHL

RDHL

Redhill Biopharm
NASDAQ
0.7500
-0.0311
-3.98%
Closed 15:59 03/27 EDT
OPEN
0.8299
PREV CLOSE
0.7811
HIGH
0.8299
LOW
0.7500
VOLUME
28.65K
TURNOVER
--
52 WEEK HIGH
3.310
52 WEEK LOW
0.7500
MARKET CAP
3.83M
P/E (TTM)
-0.3275
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at RDHL last week (0316-0320)?
Weekly Report · 5d ago
Weekly Report: what happened at RDHL last week (0309-0313)?
Weekly Report · 03/16 10:06
Weekly Report: what happened at RDHL last week (0302-0306)?
Weekly Report · 03/09 10:06
RedHill Biopharma Shareholders Approve RSU Grants and Share Capital Increase
TipRanks · 03/05 14:32
Cumberland Pharmaceuticals 2025 revenue rises 
Reuters · 03/03 22:12
Weekly Report: what happened at RDHL last week (0223-0227)?
Weekly Report · 03/02 10:06
RedHill Biopharma announces full sales and operational launch of Talicia
TipRanks · 02/25 12:17
RedHill Biopharma Says Full Sales And Operational Launch Of Talicia, Under Joint Commercialization Agreement Between Talicia And Cumberland Pharmaceuticals Has started
Benzinga · 02/25 12:11
More
About RDHL
RedHill Biopharma Ltd is an Israel-based specialty biopharmaceutical company primarily focused on gastrointestinal and infectious diseases. RedHill promotes the gastrointestinal drugs such as, Talicia for the treatment of Helicobacter pylori (H. pylori) infection, and Aemcolo, for the treatment of travelers’ diarrhea. RedHill’s clinical late-stage development programs include: :info: RHB-204, for pulmonary nontuberculous mycobacteria (NTM) disease; opaganib (ABC294640), host-directed, SPHK2 inhibitor targeting multiple indications, RHB-107 (upamostat), an oral, host-directed serine protease inhibitor with potential for pandemic preparedness, is in late-stage development for treatment of non-hospitalized symptomatic COVID-19, and is targeting multiple other cancer and inflammatory gastrointestinal diseases; RHB-104 for Crohn's disease; and RHB-102 for chemotherapy and radiotherapy induced nausea and vomiting.

Webull offers RedHill Biopharma Ltd (ADR) stock information, including NASDAQ: RDHL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RDHL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RDHL stock methods without spending real money on the virtual paper trading platform.